under $8 is good entry IMO..read the transacript and see..lots of partnerships, distributors coming on next 1-2 qtrs.
Gene therapy works....
and phase 2 is ONLY being done for high dose patients. Also, thestreet talks about more placebo patients than high dose...who cares !! they can have 2000 placebo and 9 high dose patients..the 88% is based on high dose patients ! and they say low and medium dose did not work..who cares ! high dose does work very well, and it is the one only being used for phase 2...not low and medium.
they DO NOT have the results 1 month before..it will be unblinded end of April and goes straight to FDA.
Also, EVERY bio company that does ph 2 does it with larger population than ph 1...and ph 3 is bigger than ph 2. This is not new information. All companies in clinical trials do this.
I bet we will see some covering very soon. At this price shorts should be more concerned than longs. Market cap 400M, market over 4-5 billion.
reduction...CLDN showed 88% and just needs to show above 40% for phase 2. And the 250 patients is the largest cardovasular phase 2 ever done...so phase III will not be needed.
as gene therapy...if AAV worked for Qure it will work for CLDN too. It is that simple.
its on their website..go to the publications link. There is a slide on this. THIS IS PROVEN TECHNOLOGY guys ! AAV is already approved in Europe and QURE is doing phs III on this. But too bad QURE does not have breakthrough like CLDN does.
And Bristol Myers just put 100 million on them...so the technology works.
they had their fun..now time to run up to 24 next week.
IT IS NOT FIRST TIME GENE THERAPY !! QURE already has the same gene therapy vector AAV approved for use in Europe !! Look it up.
in a spike in stock price.
usually bio stocks run up before data....going down is not good. Plus they did a secondary 3 weeks ago...so raising money just before data is also not good sign.
Pfizer, Bristol Myers also investors in ATHX..look at it now.
This could be why hospitalizations were much less for dose arm than placebo. With 250 patients now with Ph 2, the 45% hospalization target is not so low anymore ??
Placebo High Dose Arm
High Cholesterol 92% 44%
Hypertension 71% 44%
Arrhythmia 71% 55%
CAD 71% 22%
MI 57% 22%
Angina 35% 11%
PVD 28% 0%
Ischemic HD 50% 22%
that's because I sold, and am looking to get in at lower prices..so trying to scare people here a bit.
both are in phase 2....WHY ??